Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Some News Anyway. No Effect Though

<< Previous

Bullboard Posts

Next >>

Comment by The300on Feb 10, 2012 2:19pm

165 Views

Post# 19517279

RE: RE: RE: RE: Some News Anyway. No Effect Though

I know the feeling. I'm down about $80K on Halo and still holding. Current management has done more harm to this company than any comments either you or i could make.

With the right management team in place, Halo could have a very bright future as the fundamentals are still very good. The main issue is that management doesn't know or care to market this company. An inconsequential press release every 2 to 3 months is about as far as managment has gone to market this company and the results are evident.

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features